Vanda Pharmaceuticals
VNDA
VNDA
164 hedge funds and large institutions have $759M invested in Vanda Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 64 increasing their positions, 56 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
27% less call options, than puts
Call options by funds: $661K | Put options by funds: $910K
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
38% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 34
Holders
164
Holding in Top 10
2
Calls
$661K
Puts
$910K
Top Buyers
| 1 | +$44.5M | |
| 2 | +$13.4M | |
| 3 | +$8.38M | |
| 4 |
BlackRock
New York
|
+$6.31M |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$3.49M |
Top Sellers
| 1 | -$9.47M | |
| 2 | -$8.9M | |
| 3 | -$5.37M | |
| 4 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
-$4.17M |
| 5 |
First Manhattan
New York
|
-$3.79M |